Yuhan Corp
KRX:000105
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Y
|
Yuhan Corp
KRX:000105
|
KR |
|
E
|
Exor NV
XMUN:EYX
|
NL |
|
Taylor Wimpey PLC
OTC:TWODF
|
UK |
|
B
|
BioCryst Pharmaceuticals Inc
XMUN:BO1
|
US |
|
D
|
DYD Co Ltd
KOSDAQ:219550
|
KR |
|
D
|
Disco Corp
F:D65
|
JP |
|
Marathon Petroleum Corp
NYSE:MPC
|
US |
|
C
|
Christian Dior SE
XMUN:DIO
|
FR |
|
B
|
Bac A Commercial Joint Stock Bank
VN:BAB
|
VN |
|
Danone SA
PAR:BN
|
FR |
Intrinsic Value
Is Yuhan Corp undervalued or overvalued?
See the intrinsic value estimate for
Yuhan Corp and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
Yuhan Corp looks overvalued.
But is it expensive by its own standards?
See how today’s valuation compares with Yuhan Corp’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What Yuhan Does
Yuhan Corp is a South Korean pharmaceutical company that makes and sells prescription medicines, over-the-counter drugs, and health supplements. It also develops new drugs, so the business is not just a seller of finished products but also a drug creator with its own research and development work. Its customers include hospitals, clinics, pharmacies, and consumers who buy medicines and wellness products.
- Headquarters
- Korea KR
- IPO date
- Nov 1, 1962
Revenue & Expenses Breakdown
Yuhan Corp
Earnings Waterfall
Yuhan Corp
The intrinsic value for
Yuhan Corp (000105) under the Base Case is hidden KRW.
Compared with the current market price of 65 200 KRW, the stock appears hidden.